歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Angiogenesis > PP2

瀏覽歷史

S80461

PP2

源葉(MedMol) 98%
  • 英文名:
  • PP2
  • 別名:
  • AG 1879;1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-
  • CAS號(hào):
  • 172889-27-9
  • 分子式:
  • C15H16ClN5
  • 分子量:
  • 301.77
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S80461-1mg 98% ¥224.00元 7 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-2mg 98% ¥320.00元 10 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-5mg 98% ¥464.00元 7 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-10mg 98% ¥800.00元 8 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-25mg 98% ¥1120.00元 8 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-50mg 98% ¥1920.00元 5 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80461-100mg 98% ¥3200.00元 4 - - - EA 加入購(gòu)物車(chē)
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: PP2 is a reversible and ATP-competitive Src family kinases inhibitor with IC50s of 4 and 5 nM for Lck and Fyn, respectively.
  • 靶點(diǎn): IC50: 4 nM (Lck), 5 nM (Fyn);EGFR;TyrosineKinases;JAK;Src
  • 體內(nèi)研究:
    The tumor growth inhibition rate is 25% in the PP2 treatment group and 5% in the Gemcitabine treatment group (P>0.05). When administered in combination, PP2 and Gemcitabine produce a tumor growth inhibition rate of 98% (P<0.05). Hepatic metastasis occurred in 100% of control and Gemcitabine-treated groups; 88% of the PP2-treated group developed liver metastases. There are no detectable metastases in the group treated with PP2 and Gemcitabine in combination (P<0.05)
  • 參考文獻(xiàn):
    1. Hanke JH, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependentT cell activation. J Biol Chem. 1996 Jan 12;271(2):695-701. 2. Duxbury MS, et al. Inhibition of SRC tyrosine kinase impairs inherent and acquired Gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res. 2004 Apr 1;10(7):2307-18 3. Summy JM, et al. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol Cancer Ther. 2005 D 4. Inoue A, et al. Phosphorylation of NMDA receptor GluN2B subunit at Tyr1472 is important for trigeminal processing of itch. Eur J Neurosci. 2016 Oct;44(7):2474-2482.
  • 溶解性: DMSO  :  50  mg/mL  (165.69  mM;  Need  ultrasonic)    H2O  :  <  0.1  mg/mL  (insoluble)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 3.314 ml 16.569 ml 33.138 ml
    5 mM 0.663 ml 3.314 ml 6.628 ml
    10 mM 0.331 ml 1.657 ml 3.314 ml
    50 mM 0.066 ml 0.331 ml 0.663 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。